nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A3—Melphalan—ovarian cancer	0.302	0.576	CbGbCtD
Clonidine—ABCB1—ovarian cancer	0.218	1	CbGaD
Clonidine—ABCB1—Topotecan—ovarian cancer	0.033	0.0629	CbGbCtD
Clonidine—CYP3A5—Paclitaxel—ovarian cancer	0.0251	0.0478	CbGbCtD
Clonidine—ABCB1—Vinorelbine—ovarian cancer	0.0233	0.0443	CbGbCtD
Clonidine—CYP2D6—Vinorelbine—ovarian cancer	0.0219	0.0418	CbGbCtD
Clonidine—CYP3A4—Topotecan—ovarian cancer	0.0198	0.0377	CbGbCtD
Clonidine—CYP3A5—Docetaxel—ovarian cancer	0.0182	0.0346	CbGbCtD
Clonidine—ABCB1—Paclitaxel—ovarian cancer	0.0164	0.0311	CbGbCtD
Clonidine—CYP3A4—Vinorelbine—ovarian cancer	0.0139	0.0266	CbGbCtD
Clonidine—ABCB1—Docetaxel—ovarian cancer	0.0118	0.0225	CbGbCtD
Clonidine—CYP3A4—Paclitaxel—ovarian cancer	0.0098	0.0187	CbGbCtD
Clonidine—ABCB1—Doxorubicin—ovarian cancer	0.00881	0.0168	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—ovarian cancer	0.0083	0.0158	CbGbCtD
Clonidine—CYP3A4—Docetaxel—ovarian cancer	0.00708	0.0135	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—ovarian cancer	0.00528	0.0101	CbGbCtD
Clonidine—NISCH—Paclitaxel—Docetaxel—ovarian cancer	0.00242	0.446	CbGdCrCtD
Clonidine—NISCH—uterine cervix—ovarian cancer	0.00173	0.0289	CbGeAlD
Clonidine—NISCH—Vincristine—Vinorelbine—ovarian cancer	0.00167	0.307	CbGdCrCtD
Clonidine—NISCH—decidua—ovarian cancer	0.00165	0.0275	CbGeAlD
Clonidine—SLC22A4—myometrium—ovarian cancer	0.00147	0.0246	CbGeAlD
Clonidine—ADRA1D—epithelium—ovarian cancer	0.00146	0.0243	CbGeAlD
Clonidine—NISCH—uterus—ovarian cancer	0.00144	0.0241	CbGeAlD
Clonidine—NISCH—Vinblastine—Vinorelbine—ovarian cancer	0.00134	0.247	CbGdCrCtD
Clonidine—SLC22A3—myometrium—ovarian cancer	0.00134	0.0223	CbGeAlD
Clonidine—SLC22A3—embryo—ovarian cancer	0.00129	0.0215	CbGeAlD
Clonidine—NISCH—bone marrow—ovarian cancer	0.00122	0.0204	CbGeAlD
Clonidine—NISCH—female gonad—ovarian cancer	0.00118	0.0197	CbGeAlD
Clonidine—NISCH—vagina—ovarian cancer	0.00117	0.0196	CbGeAlD
Clonidine—SLC22A4—decidua—ovarian cancer	0.00109	0.0182	CbGeAlD
Clonidine—ADRA1D—female reproductive system—ovarian cancer	0.00108	0.0181	CbGeAlD
Clonidine—NISCH—testis—ovarian cancer	0.00105	0.0175	CbGeAlD
Clonidine—SLC22A3—uterine cervix—ovarian cancer	0.00104	0.0174	CbGeAlD
Clonidine—SLC22A4—endometrium—ovarian cancer	0.00103	0.0173	CbGeAlD
Clonidine—ADRA2C—myometrium—ovarian cancer	0.00101	0.017	CbGeAlD
Clonidine—SLC22A5—myometrium—ovarian cancer	0.000972	0.0162	CbGeAlD
Clonidine—SLC22A3—endometrium—ovarian cancer	0.000941	0.0157	CbGeAlD
Clonidine—Diclofenac—CXCL8—ovarian cancer	0.000939	0.801	CrCbGaD
Clonidine—SLC22A3—gonad—ovarian cancer	0.000873	0.0146	CbGeAlD
Clonidine—SLC22A4—female reproductive system—ovarian cancer	0.000856	0.0143	CbGeAlD
Clonidine—SLC6A2—decidua—ovarian cancer	0.000849	0.0142	CbGeAlD
Clonidine—ADRA1A—epithelium—ovarian cancer	0.000836	0.014	CbGeAlD
Clonidine—ADRA2A—myometrium—ovarian cancer	0.00081	0.0135	CbGeAlD
Clonidine—SLC22A4—bone marrow—ovarian cancer	0.000809	0.0135	CbGeAlD
Clonidine—ADRA2C—uterine cervix—ovarian cancer	0.00079	0.0132	CbGeAlD
Clonidine—SLC22A3—female reproductive system—ovarian cancer	0.000779	0.013	CbGeAlD
Clonidine—SLC22A4—vagina—ovarian cancer	0.000775	0.0129	CbGeAlD
Clonidine—NISCH—lymph node—ovarian cancer	0.000758	0.0127	CbGeAlD
Clonidine—SLC22A5—uterine cervix—ovarian cancer	0.000756	0.0126	CbGeAlD
Clonidine—ADRA2C—decidua—ovarian cancer	0.000752	0.0126	CbGeAlD
Clonidine—SLC6A2—gonad—ovarian cancer	0.000748	0.0125	CbGeAlD
Clonidine—SLC22A1—vagina—ovarian cancer	0.000738	0.0123	CbGeAlD
Clonidine—ADRA2C—endometrium—ovarian cancer	0.000714	0.0119	CbGeAlD
Clonidine—SLC22A3—female gonad—ovarian cancer	0.000709	0.0119	CbGeAlD
Clonidine—SLC22A3—vagina—ovarian cancer	0.000705	0.0118	CbGeAlD
Clonidine—SLC22A5—endometrium—ovarian cancer	0.000684	0.0114	CbGeAlD
Clonidine—CYP1A1—epithelium—ovarian cancer	0.000682	0.0114	CbGeAlD
Clonidine—CYP1A1—uterine cervix—ovarian cancer	0.000676	0.0113	CbGeAlD
Clonidine—SLC6A2—female reproductive system—ovarian cancer	0.000668	0.0112	CbGeAlD
Clonidine—CYP3A5—uterine cervix—ovarian cancer	0.000661	0.011	CbGeAlD
Clonidine—ADRA2C—uterus—ovarian cancer	0.000658	0.011	CbGeAlD
Clonidine—ADRA2A—uterine cervix—ovarian cancer	0.00063	0.0105	CbGeAlD
Clonidine—SLC22A3—testis—ovarian cancer	0.000629	0.0105	CbGeAlD
Clonidine—ADRA2A—decidua—ovarian cancer	0.0006	0.01	CbGeAlD
Clonidine—ADRA2A—endometrium—ovarian cancer	0.00057	0.00953	CbGeAlD
Clonidine—SLC22A5—female reproductive system—ovarian cancer	0.000567	0.00947	CbGeAlD
Clonidine—CYP1A1—uterus—ovarian cancer	0.000563	0.00942	CbGeAlD
Clonidine—SLC6A2—testis—ovarian cancer	0.000539	0.00901	CbGeAlD
Clonidine—ADRA2C—female gonad—ovarian cancer	0.000538	0.009	CbGeAlD
Clonidine—ADRA2C—vagina—ovarian cancer	0.000535	0.00895	CbGeAlD
Clonidine—ADRA2A—gonad—ovarian cancer	0.000529	0.00884	CbGeAlD
Clonidine—ADRA2A—uterus—ovarian cancer	0.000525	0.00878	CbGeAlD
Clonidine—SLC22A5—female gonad—ovarian cancer	0.000516	0.00862	CbGeAlD
Clonidine—SLC22A5—vagina—ovarian cancer	0.000513	0.00857	CbGeAlD
Clonidine—CYP1A1—female reproductive system—ovarian cancer	0.000506	0.00847	CbGeAlD
Clonidine—SLC22A4—lymph node—ovarian cancer	0.000501	0.00838	CbGeAlD
Clonidine—ADRA2C—testis—ovarian cancer	0.000477	0.00798	CbGeAlD
Clonidine—ADRA2A—female reproductive system—ovarian cancer	0.000472	0.00789	CbGeAlD
Clonidine—CYP1A1—female gonad—ovarian cancer	0.000461	0.0077	CbGeAlD
Clonidine—CYP1A1—vagina—ovarian cancer	0.000458	0.00766	CbGeAlD
Clonidine—SLC22A5—testis—ovarian cancer	0.000457	0.00765	CbGeAlD
Clonidine—SLC22A3—lymph node—ovarian cancer	0.000456	0.00762	CbGeAlD
Clonidine—ABCB1—myometrium—ovarian cancer	0.000451	0.00754	CbGeAlD
Clonidine—CYP3A5—female gonad—ovarian cancer	0.000451	0.00753	CbGeAlD
Clonidine—CYP3A5—vagina—ovarian cancer	0.000448	0.00749	CbGeAlD
Clonidine—ABCB1—embryo—ovarian cancer	0.000434	0.00725	CbGeAlD
Clonidine—ADRA2A—female gonad—ovarian cancer	0.00043	0.00718	CbGeAlD
Clonidine—ADRA2A—vagina—ovarian cancer	0.000427	0.00714	CbGeAlD
Clonidine—SLC6A2—lymph node—ovarian cancer	0.000391	0.00653	CbGeAlD
Clonidine—ADRA2A—testis—ovarian cancer	0.000381	0.00637	CbGeAlD
Clonidine—CYP3A4—female reproductive system—ovarian cancer	0.000372	0.00621	CbGeAlD
Clonidine—CYP2D6—female reproductive system—ovarian cancer	0.000366	0.00611	CbGeAlD
Clonidine—ABCB1—epithelium—ovarian cancer	0.000354	0.00592	CbGeAlD
Clonidine—ABCB1—uterine cervix—ovarian cancer	0.000351	0.00587	CbGeAlD
Clonidine—ADRA2C—lymph node—ovarian cancer	0.000346	0.00579	CbGeAlD
Clonidine—ABCB1—decidua—ovarian cancer	0.000335	0.00559	CbGeAlD
Clonidine—CYP2D6—female gonad—ovarian cancer	0.000333	0.00556	CbGeAlD
Clonidine—SLC22A5—lymph node—ovarian cancer	0.000332	0.00554	CbGeAlD
Clonidine—ABCB1—endometrium—ovarian cancer	0.000318	0.00531	CbGeAlD
Clonidine—CYP1A1—lymph node—ovarian cancer	0.000296	0.00495	CbGeAlD
Clonidine—CYP2D6—testis—ovarian cancer	0.000295	0.00493	CbGeAlD
Clonidine—ABCB1—gonad—ovarian cancer	0.000295	0.00492	CbGeAlD
Clonidine—ABCB1—uterus—ovarian cancer	0.000293	0.00489	CbGeAlD
Clonidine—ADRA2A—lymph node—ovarian cancer	0.000276	0.00462	CbGeAlD
Clonidine—ABCB1—female reproductive system—ovarian cancer	0.000263	0.0044	CbGeAlD
Clonidine—ABCB1—bone marrow—ovarian cancer	0.000248	0.00415	CbGeAlD
Clonidine—ABCB1—female gonad—ovarian cancer	0.000239	0.004	CbGeAlD
Clonidine—ABCB1—vagina—ovarian cancer	0.000238	0.00398	CbGeAlD
Clonidine—Diclofenac—ABCB1—ovarian cancer	0.000233	0.199	CrCbGaD
Clonidine—ABCB1—testis—ovarian cancer	0.000212	0.00355	CbGeAlD
Clonidine—Chest pain—Paclitaxel—ovarian cancer	0.000203	0.00126	CcSEcCtD
Clonidine—Nasopharyngitis—Epirubicin—ovarian cancer	0.000202	0.00126	CcSEcCtD
Clonidine—Anxiety—Paclitaxel—ovarian cancer	0.000202	0.00126	CcSEcCtD
Clonidine—Erythema—Docetaxel—ovarian cancer	0.000202	0.00125	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000201	0.00125	CcSEcCtD
Clonidine—Nausea—Topotecan—ovarian cancer	0.0002	0.00125	CcSEcCtD
Clonidine—Discomfort—Paclitaxel—ovarian cancer	0.0002	0.00124	CcSEcCtD
Clonidine—Dry mouth—Paclitaxel—ovarian cancer	0.000198	0.00123	CcSEcCtD
Clonidine—Diarrhoea—Vinorelbine—ovarian cancer	0.000197	0.00123	CcSEcCtD
Clonidine—Nausea—Melphalan—ovarian cancer	0.000196	0.00122	CcSEcCtD
Clonidine—Confusional state—Paclitaxel—ovarian cancer	0.000196	0.00122	CcSEcCtD
Clonidine—Asthma—Epirubicin—ovarian cancer	0.000195	0.00121	CcSEcCtD
Clonidine—Oedema—Paclitaxel—ovarian cancer	0.000194	0.00121	CcSEcCtD
Clonidine—Muscle spasms—Docetaxel—ovarian cancer	0.000194	0.00121	CcSEcCtD
Clonidine—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000193	0.0012	CcSEcCtD
Clonidine—Infection—Paclitaxel—ovarian cancer	0.000193	0.0012	CcSEcCtD
Clonidine—Shock—Paclitaxel—ovarian cancer	0.000191	0.00119	CcSEcCtD
Clonidine—Dizziness—Vinorelbine—ovarian cancer	0.000191	0.00119	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000191	0.00119	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000191	0.00119	CcSEcCtD
Clonidine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00019	0.00118	CcSEcCtD
Clonidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00019	0.00118	CcSEcCtD
Clonidine—Tachycardia—Paclitaxel—ovarian cancer	0.000189	0.00118	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—ovarian cancer	0.000189	0.00117	CcSEcCtD
Clonidine—Skin disorder—Paclitaxel—ovarian cancer	0.000189	0.00117	CcSEcCtD
Clonidine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000188	0.00117	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000187	0.00116	CcSEcCtD
Clonidine—Anorexia—Paclitaxel—ovarian cancer	0.000185	0.00115	CcSEcCtD
Clonidine—Vomiting—Vinorelbine—ovarian cancer	0.000184	0.00114	CcSEcCtD
Clonidine—Dysuria—Epirubicin—ovarian cancer	0.000182	0.00114	CcSEcCtD
Clonidine—Rash—Vinorelbine—ovarian cancer	0.000182	0.00113	CcSEcCtD
Clonidine—Dermatitis—Vinorelbine—ovarian cancer	0.000182	0.00113	CcSEcCtD
Clonidine—Hypotension—Paclitaxel—ovarian cancer	0.000181	0.00113	CcSEcCtD
Clonidine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000181	0.00113	CcSEcCtD
Clonidine—Headache—Vinorelbine—ovarian cancer	0.000181	0.00112	CcSEcCtD
Clonidine—Syncope—Docetaxel—ovarian cancer	0.000181	0.00112	CcSEcCtD
Clonidine—Asthma—Doxorubicin—ovarian cancer	0.000181	0.00112	CcSEcCtD
Clonidine—Pollakiuria—Epirubicin—ovarian cancer	0.00018	0.00112	CcSEcCtD
Clonidine—Palpitations—Docetaxel—ovarian cancer	0.000178	0.00111	CcSEcCtD
Clonidine—Weight increased—Epirubicin—ovarian cancer	0.000178	0.0011	CcSEcCtD
Clonidine—Loss of consciousness—Docetaxel—ovarian cancer	0.000177	0.0011	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000177	0.0011	CcSEcCtD
Clonidine—Cough—Docetaxel—ovarian cancer	0.000176	0.00109	CcSEcCtD
Clonidine—Insomnia—Paclitaxel—ovarian cancer	0.000176	0.00109	CcSEcCtD
Clonidine—Paraesthesia—Paclitaxel—ovarian cancer	0.000174	0.00108	CcSEcCtD
Clonidine—Drowsiness—Epirubicin—ovarian cancer	0.000174	0.00108	CcSEcCtD
Clonidine—Dyspnoea—Paclitaxel—ovarian cancer	0.000173	0.00108	CcSEcCtD
Clonidine—Somnolence—Paclitaxel—ovarian cancer	0.000173	0.00107	CcSEcCtD
Clonidine—Chest pain—Docetaxel—ovarian cancer	0.000172	0.00107	CcSEcCtD
Clonidine—Arthralgia—Docetaxel—ovarian cancer	0.000172	0.00107	CcSEcCtD
Clonidine—Nausea—Vinorelbine—ovarian cancer	0.000171	0.00107	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00017	0.00106	CcSEcCtD
Clonidine—Urinary tract infection—Epirubicin—ovarian cancer	0.000169	0.00105	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—ovarian cancer	0.000169	0.00105	CcSEcCtD
Clonidine—Decreased appetite—Paclitaxel—ovarian cancer	0.000169	0.00105	CcSEcCtD
Clonidine—Dry mouth—Docetaxel—ovarian cancer	0.000168	0.00104	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000168	0.00104	CcSEcCtD
Clonidine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000168	0.00104	CcSEcCtD
Clonidine—Fatigue—Paclitaxel—ovarian cancer	0.000167	0.00104	CcSEcCtD
Clonidine—Sweating—Epirubicin—ovarian cancer	0.000167	0.00104	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—ovarian cancer	0.000167	0.00104	CcSEcCtD
Clonidine—Constipation—Paclitaxel—ovarian cancer	0.000166	0.00103	CcSEcCtD
Clonidine—Pain—Paclitaxel—ovarian cancer	0.000166	0.00103	CcSEcCtD
Clonidine—Confusional state—Docetaxel—ovarian cancer	0.000166	0.00103	CcSEcCtD
Clonidine—Oedema—Docetaxel—ovarian cancer	0.000165	0.00102	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—ovarian cancer	0.000164	0.00102	CcSEcCtD
Clonidine—Epistaxis—Epirubicin—ovarian cancer	0.000164	0.00102	CcSEcCtD
Clonidine—Infection—Docetaxel—ovarian cancer	0.000163	0.00102	CcSEcCtD
Clonidine—Shock—Docetaxel—ovarian cancer	0.000162	0.00101	CcSEcCtD
Clonidine—Nervous system disorder—Docetaxel—ovarian cancer	0.000161	0.001	CcSEcCtD
Clonidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000161	0.001	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—ovarian cancer	0.000161	0.001	CcSEcCtD
Clonidine—Tachycardia—Docetaxel—ovarian cancer	0.000161	0.000999	CcSEcCtD
Clonidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.00016	0.000995	CcSEcCtD
Clonidine—Skin disorder—Docetaxel—ovarian cancer	0.00016	0.000994	CcSEcCtD
Clonidine—Bradycardia—Epirubicin—ovarian cancer	0.000159	0.000989	CcSEcCtD
Clonidine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000159	0.000987	CcSEcCtD
Clonidine—Anorexia—Docetaxel—ovarian cancer	0.000157	0.000976	CcSEcCtD
Clonidine—Rhinitis—Epirubicin—ovarian cancer	0.000157	0.000974	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000157	0.000974	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—ovarian cancer	0.000156	0.000972	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000155	0.000967	CcSEcCtD
Clonidine—Sweating—Doxorubicin—ovarian cancer	0.000154	0.00096	CcSEcCtD
Clonidine—Urticaria—Paclitaxel—ovarian cancer	0.000154	0.000959	CcSEcCtD
Clonidine—ABCB1—lymph node—ovarian cancer	0.000154	0.00257	CbGeAlD
Clonidine—Hypotension—Docetaxel—ovarian cancer	0.000154	0.000956	CcSEcCtD
Clonidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000153	0.000955	CcSEcCtD
Clonidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000153	0.000955	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—ovarian cancer	0.000152	0.000945	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00015	0.000933	CcSEcCtD
Clonidine—Insomnia—Docetaxel—ovarian cancer	0.000149	0.000926	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—ovarian cancer	0.000148	0.000919	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—ovarian cancer	0.000147	0.000915	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—ovarian cancer	0.000147	0.000913	CcSEcCtD
Clonidine—Somnolence—Docetaxel—ovarian cancer	0.000146	0.00091	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—ovarian cancer	0.000146	0.000908	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—ovarian cancer	0.000146	0.000906	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—ovarian cancer	0.000145	0.000902	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—ovarian cancer	0.000145	0.000901	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—ovarian cancer	0.000145	0.000899	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000144	0.000895	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—ovarian cancer	0.000143	0.00089	CcSEcCtD
Clonidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000143	0.00089	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000142	0.000884	CcSEcCtD
Clonidine—Fatigue—Docetaxel—ovarian cancer	0.000142	0.000882	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—ovarian cancer	0.000142	0.000882	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—ovarian cancer	0.000141	0.000876	CcSEcCtD
Clonidine—Pain—Docetaxel—ovarian cancer	0.000141	0.000875	CcSEcCtD
Clonidine—Constipation—Docetaxel—ovarian cancer	0.000141	0.000875	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—ovarian cancer	0.00014	0.000868	CcSEcCtD
Clonidine—Asthenia—Paclitaxel—ovarian cancer	0.000139	0.000866	CcSEcCtD
Clonidine—Alopecia—Epirubicin—ovarian cancer	0.000138	0.000859	CcSEcCtD
Clonidine—Pruritus—Paclitaxel—ovarian cancer	0.000137	0.000854	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—ovarian cancer	0.000137	0.000851	CcSEcCtD
Clonidine—Erythema—Epirubicin—ovarian cancer	0.000136	0.000846	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000136	0.000843	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—ovarian cancer	0.000135	0.00084	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—ovarian cancer	0.000135	0.000838	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000135	0.000837	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000134	0.000834	CcSEcCtD
Clonidine—Tension—Epirubicin—ovarian cancer	0.000133	0.00083	CcSEcCtD
Clonidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000133	0.000826	CcSEcCtD
Clonidine—Nervousness—Epirubicin—ovarian cancer	0.000132	0.000822	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—ovarian cancer	0.000131	0.000816	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—ovarian cancer	0.000131	0.000813	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00013	0.00081	CcSEcCtD
Clonidine—Body temperature increased—Docetaxel—ovarian cancer	0.00013	0.000809	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—ovarian cancer	0.00013	0.000809	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—ovarian cancer	0.000129	0.000803	CcSEcCtD
Clonidine—Dizziness—Paclitaxel—ovarian cancer	0.000128	0.000799	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—ovarian cancer	0.000128	0.000797	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—ovarian cancer	0.000128	0.000795	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—ovarian cancer	0.000127	0.000788	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000126	0.000785	CcSEcCtD
Clonidine—Erythema—Doxorubicin—ovarian cancer	0.000126	0.000783	CcSEcCtD
Clonidine—Agitation—Epirubicin—ovarian cancer	0.000125	0.000777	CcSEcCtD
Clonidine—Tension—Doxorubicin—ovarian cancer	0.000123	0.000768	CcSEcCtD
Clonidine—Vomiting—Paclitaxel—ovarian cancer	0.000123	0.000768	CcSEcCtD
Clonidine—Malaise—Epirubicin—ovarian cancer	0.000123	0.000763	CcSEcCtD
Clonidine—Rash—Paclitaxel—ovarian cancer	0.000122	0.000761	CcSEcCtD
Clonidine—Dermatitis—Paclitaxel—ovarian cancer	0.000122	0.000761	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—ovarian cancer	0.000122	0.00076	CcSEcCtD
Clonidine—Syncope—Epirubicin—ovarian cancer	0.000122	0.000759	CcSEcCtD
Clonidine—Headache—Paclitaxel—ovarian cancer	0.000122	0.000757	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000121	0.000754	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—ovarian cancer	0.000121	0.000753	CcSEcCtD
Clonidine—Palpitations—Epirubicin—ovarian cancer	0.00012	0.000748	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—ovarian cancer	0.00012	0.000744	CcSEcCtD
Clonidine—Cough—Epirubicin—ovarian cancer	0.000119	0.000738	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—ovarian cancer	0.000119	0.000738	CcSEcCtD
Clonidine—Asthenia—Docetaxel—ovarian cancer	0.000118	0.000734	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000117	0.000726	CcSEcCtD
Clonidine—Pruritus—Docetaxel—ovarian cancer	0.000116	0.000724	CcSEcCtD
Clonidine—Chest pain—Epirubicin—ovarian cancer	0.000116	0.00072	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—ovarian cancer	0.000116	0.00072	CcSEcCtD
Clonidine—Agitation—Doxorubicin—ovarian cancer	0.000116	0.000719	CcSEcCtD
Clonidine—Anxiety—Epirubicin—ovarian cancer	0.000115	0.000718	CcSEcCtD
Clonidine—Nausea—Paclitaxel—ovarian cancer	0.000115	0.000717	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000115	0.000715	CcSEcCtD
Clonidine—Discomfort—Epirubicin—ovarian cancer	0.000114	0.000712	CcSEcCtD
Clonidine—Malaise—Doxorubicin—ovarian cancer	0.000113	0.000706	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—ovarian cancer	0.000113	0.000704	CcSEcCtD
Clonidine—Syncope—Doxorubicin—ovarian cancer	0.000113	0.000702	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—ovarian cancer	0.000113	0.0007	CcSEcCtD
Clonidine—Confusional state—Epirubicin—ovarian cancer	0.000112	0.000696	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—ovarian cancer	0.000111	0.000692	CcSEcCtD
Clonidine—Oedema—Epirubicin—ovarian cancer	0.000111	0.00069	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000111	0.000688	CcSEcCtD
Clonidine—Infection—Epirubicin—ovarian cancer	0.00011	0.000686	CcSEcCtD
Clonidine—Cough—Doxorubicin—ovarian cancer	0.00011	0.000683	CcSEcCtD
Clonidine—Shock—Epirubicin—ovarian cancer	0.000109	0.000679	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—ovarian cancer	0.000109	0.000677	CcSEcCtD
Clonidine—Dizziness—Docetaxel—ovarian cancer	0.000109	0.000677	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000109	0.000676	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—ovarian cancer	0.000108	0.000674	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—ovarian cancer	0.000108	0.000671	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000107	0.000667	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—ovarian cancer	0.000107	0.000666	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—ovarian cancer	0.000107	0.000666	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—ovarian cancer	0.000107	0.000664	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000106	0.000662	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—ovarian cancer	0.000106	0.000658	CcSEcCtD
Clonidine—Anorexia—Epirubicin—ovarian cancer	0.000106	0.000658	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—ovarian cancer	0.000105	0.000652	CcSEcCtD
Clonidine—Vomiting—Docetaxel—ovarian cancer	0.000105	0.000651	CcSEcCtD
Clonidine—Rash—Docetaxel—ovarian cancer	0.000104	0.000645	CcSEcCtD
Clonidine—Hypotension—Epirubicin—ovarian cancer	0.000104	0.000645	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—ovarian cancer	0.000104	0.000645	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—ovarian cancer	0.000104	0.000644	CcSEcCtD
Clonidine—Headache—Docetaxel—ovarian cancer	0.000103	0.000641	CcSEcCtD
Clonidine—Oedema—Doxorubicin—ovarian cancer	0.000103	0.000639	CcSEcCtD
Clonidine—Infection—Doxorubicin—ovarian cancer	0.000102	0.000635	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000101	0.000629	CcSEcCtD
Clonidine—Shock—Doxorubicin—ovarian cancer	0.000101	0.000628	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000101	0.000626	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000101	0.000625	CcSEcCtD
Clonidine—Insomnia—Epirubicin—ovarian cancer	0.0001	0.000624	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—ovarian cancer	0.0001	0.000623	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—ovarian cancer	9.97e-05	0.00062	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—ovarian cancer	9.97e-05	0.00062	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—ovarian cancer	9.93e-05	0.000618	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—ovarian cancer	9.89e-05	0.000616	CcSEcCtD
Clonidine—Somnolence—Epirubicin—ovarian cancer	9.87e-05	0.000614	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—ovarian cancer	9.79e-05	0.000609	CcSEcCtD
Clonidine—Nausea—Docetaxel—ovarian cancer	9.77e-05	0.000608	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—ovarian cancer	9.65e-05	0.0006	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—ovarian cancer	9.6e-05	0.000597	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.58e-05	0.000596	CcSEcCtD
Clonidine—Fatigue—Epirubicin—ovarian cancer	9.57e-05	0.000595	CcSEcCtD
Clonidine—Pain—Epirubicin—ovarian cancer	9.49e-05	0.00059	CcSEcCtD
Clonidine—Constipation—Epirubicin—ovarian cancer	9.49e-05	0.00059	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.36e-05	0.000582	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—ovarian cancer	9.29e-05	0.000578	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—ovarian cancer	9.22e-05	0.000574	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—ovarian cancer	9.16e-05	0.00057	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—ovarian cancer	9.15e-05	0.000569	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—ovarian cancer	9.13e-05	0.000568	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—ovarian cancer	9.08e-05	0.000565	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—ovarian cancer	8.93e-05	0.000555	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.87e-05	0.000552	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—ovarian cancer	8.85e-05	0.000551	CcSEcCtD
Clonidine—Urticaria—Epirubicin—ovarian cancer	8.82e-05	0.000548	CcSEcCtD
Clonidine—Constipation—Doxorubicin—ovarian cancer	8.78e-05	0.000546	CcSEcCtD
Clonidine—Pain—Doxorubicin—ovarian cancer	8.78e-05	0.000546	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—ovarian cancer	8.77e-05	0.000546	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—ovarian cancer	8.77e-05	0.000546	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—ovarian cancer	8.46e-05	0.000526	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—ovarian cancer	8.4e-05	0.000522	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—ovarian cancer	8.18e-05	0.000509	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—ovarian cancer	8.16e-05	0.000507	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—ovarian cancer	8.12e-05	0.000505	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—ovarian cancer	8.12e-05	0.000505	CcSEcCtD
Clonidine—Asthenia—Epirubicin—ovarian cancer	7.96e-05	0.000495	CcSEcCtD
Clonidine—Pruritus—Epirubicin—ovarian cancer	7.85e-05	0.000488	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—ovarian cancer	7.59e-05	0.000472	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—ovarian cancer	7.57e-05	0.000471	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—ovarian cancer	7.37e-05	0.000458	CcSEcCtD
Clonidine—Dizziness—Epirubicin—ovarian cancer	7.34e-05	0.000457	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—ovarian cancer	7.27e-05	0.000452	CcSEcCtD
Clonidine—Vomiting—Epirubicin—ovarian cancer	7.06e-05	0.000439	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—ovarian cancer	7.03e-05	0.000437	CcSEcCtD
Clonidine—Rash—Epirubicin—ovarian cancer	7e-05	0.000435	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—ovarian cancer	6.99e-05	0.000435	CcSEcCtD
Clonidine—Headache—Epirubicin—ovarian cancer	6.95e-05	0.000433	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—ovarian cancer	6.79e-05	0.000422	CcSEcCtD
Clonidine—Nausea—Epirubicin—ovarian cancer	6.59e-05	0.00041	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—ovarian cancer	6.53e-05	0.000406	CcSEcCtD
Clonidine—Rash—Doxorubicin—ovarian cancer	6.47e-05	0.000403	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—ovarian cancer	6.47e-05	0.000402	CcSEcCtD
Clonidine—Headache—Doxorubicin—ovarian cancer	6.43e-05	0.0004	CcSEcCtD
Clonidine—Nausea—Doxorubicin—ovarian cancer	6.1e-05	0.000379	CcSEcCtD
Clonidine—ADRA2A—Signaling Pathways—ESR1—ovarian cancer	4.36e-06	0.000146	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—PIK3CA—ovarian cancer	4.35e-06	0.000146	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CD—ovarian cancer	4.34e-06	0.000146	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CDKN1B—ovarian cancer	4.33e-06	0.000145	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KRAS—ovarian cancer	4.3e-06	0.000144	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PIK3CA—ovarian cancer	4.3e-06	0.000144	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6ST—ovarian cancer	4.29e-06	0.000144	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—ovarian cancer	4.28e-06	0.000144	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CG—ovarian cancer	4.27e-06	0.000143	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—MAPK3—ovarian cancer	4.25e-06	0.000143	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—ovarian cancer	4.24e-06	0.000142	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL2—ovarian cancer	4.24e-06	0.000142	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—ovarian cancer	4.22e-06	0.000142	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—ovarian cancer	4.22e-06	0.000142	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MTOR—ovarian cancer	4.17e-06	0.00014	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CB—ovarian cancer	4.17e-06	0.00014	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CCND1—ovarian cancer	4.13e-06	0.000139	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CG—ovarian cancer	4.12e-06	0.000138	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APC—ovarian cancer	4.12e-06	0.000138	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—NRAS—ovarian cancer	4.12e-06	0.000138	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CTNNB1—ovarian cancer	4.09e-06	0.000137	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.07e-06	0.000137	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.05e-06	0.000136	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—MAPK1—ovarian cancer	4.05e-06	0.000136	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—ovarian cancer	4.04e-06	0.000136	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTEN—ovarian cancer	4.02e-06	0.000135	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PIK3CA—ovarian cancer	4.02e-06	0.000135	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—ovarian cancer	4.01e-06	0.000135	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—ovarian cancer	4e-06	0.000134	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTEN—ovarian cancer	3.99e-06	0.000134	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—ovarian cancer	3.98e-06	0.000134	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CD—ovarian cancer	3.97e-06	0.000133	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PIK3CA—ovarian cancer	3.95e-06	0.000133	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK3—ovarian cancer	3.95e-06	0.000133	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—ovarian cancer	3.94e-06	0.000132	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1B—ovarian cancer	3.91e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CD—ovarian cancer	3.9e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MTOR—ovarian cancer	3.89e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CB—ovarian cancer	3.89e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—ovarian cancer	3.89e-06	0.000131	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—FASN—ovarian cancer	3.89e-06	0.00013	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—ovarian cancer	3.88e-06	0.00013	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—ovarian cancer	3.87e-06	0.00013	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.87e-06	0.00013	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—ovarian cancer	3.85e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—ovarian cancer	3.83e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CB—ovarian cancer	3.83e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MTOR—ovarian cancer	3.83e-06	0.000129	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—ovarian cancer	3.83e-06	0.000128	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.82e-06	0.000128	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—ovarian cancer	3.82e-06	0.000128	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—ovarian cancer	3.81e-06	0.000128	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—ovarian cancer	3.8e-06	0.000128	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CB—ovarian cancer	3.78e-06	0.000127	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.78e-06	0.000127	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK1—ovarian cancer	3.76e-06	0.000126	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—ovarian cancer	3.76e-06	0.000126	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.75e-06	0.000126	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CAV1—ovarian cancer	3.74e-06	0.000126	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—ovarian cancer	3.74e-06	0.000126	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—ovarian cancer	3.73e-06	0.000125	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—ovarian cancer	3.71e-06	0.000125	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TYMS—ovarian cancer	3.71e-06	0.000125	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—ovarian cancer	3.69e-06	0.000124	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.69e-06	0.000124	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—ovarian cancer	3.68e-06	0.000124	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—ovarian cancer	3.66e-06	0.000123	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1B—ovarian cancer	3.65e-06	0.000123	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—ovarian cancer	3.63e-06	0.000122	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—ovarian cancer	3.62e-06	0.000122	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—ovarian cancer	3.61e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—ovarian cancer	3.6e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—ovarian cancer	3.6e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1B—ovarian cancer	3.59e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—ovarian cancer	3.59e-06	0.000121	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—ovarian cancer	3.58e-06	0.00012	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—ovarian cancer	3.57e-06	0.00012	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—ovarian cancer	3.57e-06	0.00012	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—ovarian cancer	3.56e-06	0.000119	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—ovarian cancer	3.56e-06	0.000119	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—ovarian cancer	3.56e-06	0.000119	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—ovarian cancer	3.55e-06	0.000119	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.54e-06	0.000119	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAV1—ovarian cancer	3.53e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—ovarian cancer	3.52e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—ovarian cancer	3.52e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—ovarian cancer	3.51e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—ovarian cancer	3.51e-06	0.000118	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—ovarian cancer	3.5e-06	0.000117	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—ovarian cancer	3.48e-06	0.000117	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.46e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—ovarian cancer	3.45e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—ovarian cancer	3.45e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—ovarian cancer	3.43e-06	0.000115	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.41e-06	0.000115	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—ovarian cancer	3.41e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—ovarian cancer	3.4e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MTOR—ovarian cancer	3.4e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—ovarian cancer	3.4e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—ovarian cancer	3.38e-06	0.000114	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—ovarian cancer	3.36e-06	0.000113	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—ovarian cancer	3.33e-06	0.000112	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—ovarian cancer	3.31e-06	0.000111	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—ovarian cancer	3.31e-06	0.000111	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—ovarian cancer	3.28e-06	0.00011	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	3.27e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—ovarian cancer	3.27e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—ovarian cancer	3.27e-06	0.00011	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—ovarian cancer	3.26e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—ovarian cancer	3.25e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—ovarian cancer	3.25e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK1—ovarian cancer	3.24e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—ovarian cancer	3.24e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—ovarian cancer	3.23e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—ovarian cancer	3.22e-06	0.000108	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.21e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—ovarian cancer	3.21e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—ovarian cancer	3.2e-06	0.000108	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1B—ovarian cancer	3.19e-06	0.000107	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—ovarian cancer	3.16e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MTOR—ovarian cancer	3.16e-06	0.000106	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—ovarian cancer	3.16e-06	0.000106	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.14e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—ovarian cancer	3.13e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—ovarian cancer	3.12e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—ovarian cancer	3.11e-06	0.000104	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—ovarian cancer	3.08e-06	0.000103	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—ovarian cancer	3.06e-06	0.000103	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—ovarian cancer	3.05e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—ovarian cancer	3.04e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—ovarian cancer	3.04e-06	0.000102	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—ovarian cancer	3.02e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—ovarian cancer	3.02e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—ovarian cancer	3.01e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—ovarian cancer	3e-06	0.000101	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3e-06	0.000101	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—ovarian cancer	2.99e-06	0.0001	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—ovarian cancer	2.99e-06	0.0001	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAV1—ovarian cancer	2.99e-06	0.0001	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—ovarian cancer	2.99e-06	0.0001	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1B—ovarian cancer	2.97e-06	9.96e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—ovarian cancer	2.96e-06	9.94e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—ovarian cancer	2.96e-06	9.93e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—ovarian cancer	2.95e-06	9.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—ovarian cancer	2.94e-06	9.87e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—ovarian cancer	2.93e-06	9.85e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK1—ovarian cancer	2.93e-06	9.82e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—ovarian cancer	2.93e-06	9.82e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.92e-06	9.79e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—ovarian cancer	2.91e-06	9.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—ovarian cancer	2.9e-06	9.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—ovarian cancer	2.89e-06	9.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—ovarian cancer	2.87e-06	9.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—ovarian cancer	2.87e-06	9.63e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TYMS—ovarian cancer	2.86e-06	9.61e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.86e-06	9.59e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—ovarian cancer	2.84e-06	9.52e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—ovarian cancer	2.83e-06	9.5e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—ovarian cancer	2.83e-06	9.49e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—ovarian cancer	2.83e-06	9.49e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.83e-06	9.49e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—ovarian cancer	2.81e-06	9.44e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—ovarian cancer	2.8e-06	9.41e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—ovarian cancer	2.79e-06	9.38e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—ovarian cancer	2.76e-06	9.28e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—ovarian cancer	2.75e-06	9.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—ovarian cancer	2.75e-06	9.22e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK1—ovarian cancer	2.73e-06	9.18e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—ovarian cancer	2.73e-06	9.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—ovarian cancer	2.73e-06	9.17e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.72e-06	9.14e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—ovarian cancer	2.72e-06	9.13e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—ovarian cancer	2.72e-06	9.13e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK1—ovarian cancer	2.69e-06	9.03e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—ovarian cancer	2.69e-06	9.03e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—ovarian cancer	2.66e-06	8.94e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—ovarian cancer	2.65e-06	8.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—ovarian cancer	2.63e-06	8.82e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—ovarian cancer	2.62e-06	8.8e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.61e-06	8.77e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—ovarian cancer	2.6e-06	8.74e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—ovarian cancer	2.58e-06	8.67e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—ovarian cancer	2.54e-06	8.53e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—ovarian cancer	2.54e-06	8.52e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—ovarian cancer	2.51e-06	8.43e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—ovarian cancer	2.49e-06	8.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—ovarian cancer	2.47e-06	8.28e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.46e-06	8.27e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—ovarian cancer	2.46e-06	8.25e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—ovarian cancer	2.44e-06	8.2e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—ovarian cancer	2.44e-06	8.2e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—ovarian cancer	2.44e-06	8.18e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.39e-06	8.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK1—ovarian cancer	2.39e-06	8.02e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—ovarian cancer	2.39e-06	8.02e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—ovarian cancer	2.37e-06	7.96e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—ovarian cancer	2.35e-06	7.89e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—ovarian cancer	2.33e-06	7.84e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—ovarian cancer	2.33e-06	7.83e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—ovarian cancer	2.32e-06	7.78e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.31e-06	7.75e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—ovarian cancer	2.3e-06	7.74e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—ovarian cancer	2.3e-06	7.71e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—ovarian cancer	2.29e-06	7.7e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—ovarian cancer	2.27e-06	7.62e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—ovarian cancer	2.26e-06	7.58e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—ovarian cancer	2.26e-06	7.58e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—ovarian cancer	2.26e-06	7.58e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—ovarian cancer	2.25e-06	7.55e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—ovarian cancer	2.22e-06	7.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK1—ovarian cancer	2.22e-06	7.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—ovarian cancer	2.22e-06	7.45e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—ovarian cancer	2.19e-06	7.37e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—ovarian cancer	2.16e-06	7.25e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.13e-06	7.14e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.11e-06	7.09e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.1e-06	7.05e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—ovarian cancer	2.1e-06	7.05e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—ovarian cancer	2.1e-06	7.04e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.09e-06	7e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—ovarian cancer	2.07e-06	6.96e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—ovarian cancer	2.07e-06	6.96e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—ovarian cancer	2.07e-06	6.94e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—ovarian cancer	2.01e-06	6.73e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.99e-06	6.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—ovarian cancer	1.94e-06	6.51e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—ovarian cancer	1.93e-06	6.47e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—ovarian cancer	1.92e-06	6.44e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—ovarian cancer	1.91e-06	6.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—ovarian cancer	1.88e-06	6.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—ovarian cancer	1.86e-06	6.26e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.85e-06	6.2e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—ovarian cancer	1.84e-06	6.16e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—ovarian cancer	1.8e-06	6.05e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—ovarian cancer	1.78e-06	5.98e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—ovarian cancer	1.72e-06	5.79e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—ovarian cancer	1.71e-06	5.73e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—ovarian cancer	1.69e-06	5.69e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—ovarian cancer	1.63e-06	5.47e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.61e-06	5.41e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.59e-06	5.35e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—ovarian cancer	1.57e-06	5.28e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.5e-06	5.04e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.39e-06	4.67e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—ovarian cancer	1.3e-06	4.37e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.27e-06	4.27e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.23e-06	4.12e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.04e-06	3.49e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.82e-07	3.3e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—ovarian cancer	8.02e-07	2.69e-05	CbGpPWpGaD
